Lars Wagner, M.D.

Cincinnati Children's Hospital Medical CenterCincinnati, Ohio - 45229-3039 |
- CLINICAL TRIALS 3
- CONDITIONS6
- INTERVENTIONS13
- SINCE2005

A Pilot Study of the Addition of Bevacizumab to VOIT Regimen for Relapsed/Refractory Pediatric Solid Tumors
October 2008 - October 2010

A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung
March 2009 - September 2014

Combination Chemotherapy in Treating Patients With Stage III or Stage IV Malignant Peripheral Nerve Sheath Tumors
December 2005 - April 2012
Neoplasms
Sarcoma
Osteosarcoma
Neurofibromatoses
Neurofibromatosis 1
Nerve Sheath Neoplasms
Placebo
Filgrastim
Bevacizumab
Ifosfamide
Radiation Therapy
Temozolomide
Doxorubicin Hydrochloride
Etoposide
Vincristine Sulfate
Irinotecan
Cefixime Or Cefpodoxime
Conventional Surgery
Saracatinib



